Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Hospice of the Chesapeake Acquires Hospice of Charles County, Expands Access to Innovative Supportive Care Services


Delegate Edith Patterson, Hospice of Charles County Board Chair, with Hospice of the Chesapeake leadership Mike Brady and Regina Moody in front of the Charles County Hospice House.

“We’re grateful for the patience, dedication, and spirit of partnership that have led to this acquisition and expansion of care. We’re also immensely proud to join a small, elite group of national hospice providers that care for over 600 individuals each day.” Michael Brady, Acting HOC CEO

Hospice of the Chesapeake, one of the region’s leading providers of hospice care, supportive care, and grief support, has finalized its acquisition of Hospice of Charles County, effective October 2, 2020. As the acquisition positions Hospice of the Chesapeake as one of the largest hospice care providers in the region, the organization has introduced a new brand identity to reflect both the physical growth and significant programmatic expansion that accompanies it.

“We are grateful to the Hospice of Charles County Board of Directors and staff for their patience, dedication, and spirit of partnership that have led to this acquisition and our exciting expansion of care,” said Michael Brady, Acting CEO for Hospice of the Chesapeake. “We’re also immensely proud that this new chapter which will position us among a small, elite group of national hospice providers that care for over 600 patients and families each day.”

This growth comes at a time when the organization is significantly enhancing its care offerings. “While we’ve expanded our reach of hospice care patients over the last several years, we’ve been simultaneously broadening the type of care that we provide through innovations in supportive care,” said Brady. “We’re approaching a 30% increase in supportive care visits from 2019 to 2020 and earlier this year introduced primary complex illness care as an additional level of support for these patients.”

Hospice of the Chesapeake’s new brand identity, including redesigned program logos, imagery and key messaging, better reflects this modern, multi-directional expansion of care and signifies a new era of education and outreach within the community. “Our new look is designed to evoke a feeling of comfort, calm and ever-present support for those who are living with illness and loss,” said Chief Medical Officer Eric Bush, MD, RPh, MBA. “It’s a true representation of our evolution and recent milestones, such as our Chesapeake Supportive Care program earning The Joint Commission’s Gold Seal of Approval® for Community-Based Palliative Care Accreditation. We’re truly honored to support and comfort even more Maryland families from our new home in Charles County.”

To learn more about Hospice of the Chesapeake and its diverse programs, including: Chesapeake Supportive Care; Chesapeake Life Center; Chesapeake Kids; We Honor Veterans; and the John & Cathy Belcher Institute, visit https://www.hospicechesapeake.org/ or call 410-987-2003.

About Hospice of the Chesapeake:

For medical professionals and consumers seeking a responsive care provider, Hospice of the Chesapeake is a care organization offering hospice care, supportive care, special programs for children and Veterans and grief support services. We provide reliable, compassionate, expert care to patients and families in Anne Arundel, Charles, and Prince George’s counties in Maryland living with advanced illness and loss. Visit http://www.hospicechesapeake.org to learn more.

About Chesapeake Supportive Care:

Chesapeake Supportive Care, a program of Hospice of the Chesapeake, specializes in providing medical care that focuses on reducing the symptoms; pain and stress caused by serious illness—whatever the diagnosis. It is appropriate at any age or stage of illness and can be provided alongside curative treatment. The goal of supportive care is to improve quality of life for both patient and family. To learn more visit http://www.chesapeakesupportivecare.org.

Share article on social media or email:

Omada MSK by Physera Selected for Evernorth’s Digital Health Formulary


Cigna Corporation’s health services segment Evernorth today announced the expansion of its industry-first Digital Health Formulary, adding Omada Health’s program for at-home physical therapy and personalized coaching for chronic pain to the platform. Omada MSK by Physera joins Omada’s existing formulary programs for diabetes prevention, type 2 diabetes, and hypertension. The musculoskeletal program will be available to formulary customers beginning in 2021, giving Omada the broadest range of programs on the industry-leading platform. Created in 2019, the Digital Health Formulary features solutions that are evaluated and measured on clinical effectiveness, usability, scalability, and interoperability.

“Evernorth has made rigorous evaluation a prerequisite for any solution included on its digital health formulary,” said Omada CEO and Co-Founder Sean Duffy. “Having four Omada programs available beginning next year speaks to both the breadth and depth of virtual care that only Omada can provide. The inclusion of Omada MSK by Physera will provide the potential for tens of millions of individuals across the country to access Omada’s full suite of chronic disease programs. We’re excited to demonstrate our value for our participants, and for our partners.”

“When Physera joined the Omada portfolio of programs earlier this year, we knew we had joined a team that could expand our impact, and complement our clinical expertise in MSK care,” added Physera CEO Dan Rubinstein. “The inclusion of our musculoskeletal solution on the Evernorth Digital Health Formulary is validation of our approach to making physical therapy, and care for chronic pain, effective and accessible through technology — and is a realization of what we know our combined team can do together.”

To date, health plans covering more than 20 million Americans offer solutions from Evernorth’s Digital Health Formulary to their members. Plan sponsors can choose to invest and deploy individual solutions, or a combination of programs on the platform. In addition to rigorous measurement from physicians, pharmacists, and health research scientists, programs on the formulary are also evaluated by user-experience experts. People using programs on the Digital Health Formulary may also receive support from specialist pharmacists to further optimize the potential health benefits of the chosen solutions.

About Omada Health

Omada Health is a digital care provider that empowers people to achieve their health goals through sustainable behavioral change. Working with health plans, employers, and health systems, the company delivers personalized interventions for individuals dealing with chronic conditions, musculoskeletal issues, anxiety, and depression. Combining data-powered human coaching, connected devices, and curriculum tailored to an individual’s specific conditions and circumstances, Omada has enrolled more than 350,000 participants across all 50 states. Omada partners include Cigna, Kaiser Permanente, Blue Cross Blue Shield Minnesota, and other leading health plans.

Share article on social media or email:

The Formula To Succeed In Biopharma Manufacturing, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

During the webinar, panelists will explain how artificial intelligence allows predicting, classifying, recognizing and recommending improvements to the process which leads to enhanced product quality and process performance (2 sides of the same coin) in CPV.

Process validation encompasses a lifecycle approach which includes three stages: Process Design or Development (Stage 1), Process Performance Qualification (Stage 2) and Continued/On-going Process Verification (CPV, Stage 3). The 3 stages are typically a long manufacturing journey where extensive data is accumulated, trended, and analyzed. Thus, CPV highly recommends process automation, PAT (Process Analytical Technologies) and a deep knowledge of the manufacturing process and drug product. Continued process verification enables concepts like real time release (RTR), use of continuous manufacturing or Golden Batch, but it is still not adopted in Pharma.

The established conditions (EC), critical quality attributes (CQA), and critical process parameters (CPP) are not enough to describe a real, complete picture and history of the process. Manual operations, environmental variables, seasonality components and many other factors are affecting the process inducing a permanent variability. Statistics and multivariable analysis can be complemented with artificial intelligence (AI) to boost the stage 3 towards a reality and a continuous state of the art in biopharma manufacturing.

During the webinar, panelists will explain how artificial intelligence allows predicting, classifying, recognizing and recommending improvements to the process which leads to enhanced product quality and process performance (2 sides of the same coin) in CPV.

Join Toni Manzano, Chief Science Officer, Aizon and Raul Alba, PhD, PMP, Biotech Solutions Expert, Aizon in a live webinar on Tuesday, October 13, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit CPV + AI: The Formula To Succeed In Biopharma Manufacturing.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

hyperCORE International Names New CEO


hyperCORE International CEO Karri Venn

Karri Venn, CEO of hyperCORE International

I am honored to be voted in as CEO from my peers to take on the leadership of this amazing team.

hyperCORE International, a multi-national integrated research organization, has named Karri Venn CEO of the organization. Venn, President of Research at Canada-based LMC Manna, brings more than 22 years of research experience. LMC Manna is comprised of 20 sites and has been honored as a Centre of Excellence in Diabetes in Clinical Research and is a founding member of hyperCORE International.

“hyperCORE International is one of the premier integrated research networks in the industry and I am honored to be voted in as CEO from my peers to take on the leadership of this amazing team,” said Venn. “In a time of uncertainty, research has a vital role in finding a solution to this pandemic and the future of research sites is changing rapidly of which hyperCORE International is poised to be leading.”

The hyperCORE network is composed of 90 member sites across North and South America and offers streamlined efficiencies such as single budget and contracts, and shared platforms for rapid scalability; the network also offers unparalleled access to diverse populations and depth of expertise across all therapeutic areas including vaccine, metabolic disorders and dermatology.

About hyperCORE International:

Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. It is an industry leader, providing Phase I-IV clinical trial services with more than 90 active research sites across the globe. Its member companies have more than 100 years of combined experience and completed more than 6,000 studies helping to evaluate thousands of new drugs and treatments in more than 60,000 patients. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.

hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation.

Learn more at http://www.hyperCOREinternational.com

Share article on social media or email:

Nella NuSpec by Ceek Women’s Health Named Honoree in Fast Company’s 2020 Innovation by Design Awards


News Image

The Nella NuSpec Reusable Vaginal Speculum was honored in Fast Company’s Innovation by Design Awards for 2020 in the Health category.

The awards, which can be found in the October/November 2020 issue of Fast Company, recognize people, teams, and companies solving problems through design. One of the most sought-after design awards in the industry, Innovation by Design is the only competition to honor creative work at the intersection of design, business, and innovation.

The Nella NuSpec is the first major redesign of the reusable vaginal speculum that takes into account both the patient experience and unmet provider needs. Designed for ultimate patient comfort, the NuSpec utilizes a narrow bill—about the size of a regular tampon—with hidden sidewall retractors. Speculum insertion can be painful, but the NuSpec’s narrow size and smooth material allow it to glide in with ease. When the provider opens the device, lateral retractors retain vaginal sidewalls so providers have adequate visibility and access to conduct an exam or procedure.

For the provider, a unique toggle locking mechanism allows quiet opening and locking of the device with one-hand—unlike the metal speculum, which can make clanking, anxiety-inducing noise and requires two hands to secure. The NuSpec’s handle form and increased angle also provide improved ergonomics for clinicians, crucial for a device used constantly throughout the day.

The NuSpec can improve the exam experience for any patient, but it can make a dramatic difference for patients with increased sensitivity, such as first-time patients, post-menopausal women and cancer survivors.

“At Ceek Women’s Health, we believe in bringing both patient and clinician perspectives to the table as we work to improve medical devices used in gynecological care,” says Fahti Khosrowshahi, CEO and founder. “This honor is a testament to the extensive five-year design and development process for the Nella NuSpec, where we worked in partnership with OBGYN providers and patients, taking into consideration the needs of both parties for the first time.”

“We need innovative design more than ever, and the 2020 honorees have brought creativity, inventiveness, and humanity to address some of the world’s most pressing problems, including the global pandemic, racial injustice, and economic inequality. Together these entries offer a glimpse into a future that is more inclusive, more accessible, and more just,” said Stephanie Mehta, editor-in-chief of Fast Company.

The judges include renowned designers from a variety of disciplines, business leaders from some of the most innovative companies in the world, and Fast Company’s own writers and editors. Entries are judged on the key ingredients of innovation: functionality, originality, beauty, sustainability, user insight, cultural impact, and business impact.

Winners, finalists, and honorable mentions are featured online and in the October/November issue of Fast Company magazine, on newsstands October 20.

To see the complete list, go to: https://www.fastcompany.com/innovation-by-design/2020

ABOUT CEEK

Ceek Women’s Health is a women-led medical device company focused on creating products for a better pelvic exam. The company was born out of founder and CEO Fahti Khosrowshahi’s personal experience going through three years of infertility treatment. Ceek’s process is to understand the user experience from both the patient and clinician perspective and uncover opportunities often overlooked by standard medical device companies.

ABOUT FAST COMPANY

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Stephanie Mehta. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at fastcompany.com.

Share article on social media or email:

Health Tech Startup WellPrevail Launches Crowdfunding Campaign for Ground-Breaking Chronic Pain Management Platform


WellPervail

Chronic pain does not have to control your life.

It’s safe to say that Melissa Chua, the founder of WellPrevail, knows what she’s about. She holds a Bachelor of Science and an MPhil from the University of Sydney and is currently pursuing a Master’s degree in Bioinformatics at Johns Hopkins University — not to mention her experience as a cancer research officer in Singapore.

It comes as no surprise, then, that WellPrevail espouses a markedly scientific approach and draws on the latest medical research. What sets this startup apart, though, is its focus on people’s lived experience.

Ms. Chua knows from personal experience what it means to deal with near-constant, crippling pain. That’s why she founded WellPrevail to empower people with chronic pain to lead the best possible life.

The Project

WellPrevail recently announced that it was working to create a multidisciplinary digital pain management platform — its most ambitious project to date.

The innovative e-platform will be threefold.

The main feature will be a one-of-a-kind eHealth web app that will bring various pain management services under one roof. These include a patient portal and educational resources as well as psychological consultations and one-on-one coaching.

As a companion to the web-based app, WellPrevail is also working on a handy mobile app that packs in a diary, a symptom checker, and easy access to the user’s personal medication and physical therapy plan.

Last but not least, the new digital platform will feature a private peer-support community portal. There, patients will be able to connect with like-minded individuals, ask questions, and share their stories.

The Goal

Chronic pain affects around 20 percent of the world’s population. In addition to physical discomfort, prolonged pain can often lead to anxiety, depression, and even suicide.

With its innovative digital platform, WellPrevail seeks to improve the lives of people with chronic pain by raising awareness, building resilient communities, and connecting patients to mental health experts and coaches wherever they might be based.

The project also aims to reduce the widespread reliance on opioids by providing information on and encouraging alternative pain management treatments.

The Campaign

WellPrevail plans to crowd-fund its project through Indiegogo. The campaign is now live. It offers exclusive discounts and access to premium payment plans to the first people to donate.

Also, don’t miss out on our referral program! Share with your loved ones and receive 15% compensation.

About WellPrevail: WellPrevail is a health tech startup with a focus on chronic pain management. It was founded by a medical researcher to transform the latest scientific research into easy-to-understand, actionable information that people with chronic pain can use to improve their daily lives.

###

For more information on WellPrevail, please contact funding@wellprevail.com or visit our homepage.

Share article on social media or email:

Nurse Practitioners (NPs) Urge Better Respiratory Care to Combat Flu, COVID-19


AANP is the largest professional membership organization for nurse practitioners (NPs) of all specialties.

Patients need to understand that their respiratory health is at higher risk this fall, but there are steps they can take to protect themselves.

October is Healthy Lung Month, and the American Association of Nurse Practitioners® (AANP) is urging patients to take precautions against the list of growing threats to lung health — from COVID-19 and flu to vaping and wildfires.

“Our lungs do more than allow us to breathe. They enable every other organ in our body to function,” said AANP President Sophia L. Thomas, DNP, APRN, FNP-BC, PPCNP-BC, FNAP, FAANP. “As we continue to confront the COVID-19 pandemic and prepare for the 2020 flu season, parts of the country are dealing with the compounded respiratory threats of smoke-producing wildfires and flood-related mold issues. With so many patients potentially at risk for respiratory illness this year, AANP is urging all people to protect their lungs and avoid spreading respiratory viruses like the flu and COVID-19.”

AANP recommends patients take the following actions to protect the health of their lungs:

  • Wear a mask in public. People can significantly lower their chances of contracting or spreading COVID-19, the flu and other respiratory illnesses by wearing a face mask over their mouth and nose when out in public.
  • Get a flu vaccine. It is possible to have a concomitant infection of the flu and COVID-19. Patients can significantly lower their risk by getting a flu vaccine, which is safe, widely available and can be administered quickly by an NP or other health care provider.
  • Stop smoking or vaping. These habits not only increase the chances of developing further respiratory complications from viruses like COVID-19 and flu, but prolonged use can cause damage to the lungs and in other areas of the body.
  • Don’t wait to be tested. People experiencing symptoms of the flu or COVID-19 should call or schedule a visit with their health care provider as soon as possible. In many cases, an NP will be able to determine if you have the flu in under an hour using rapid testing capabilities.
  • Stay informed about air quality conditions. People experiencing poor air quality conditions as a result of exposure to smoke from wildfires or storm flood-related mold should stay up to date on recommendations and safety guidelines from local and state officials.
  • Schedule a visit with an NP. Since the onset of the COVID-19 pandemic, many patients have put their primary health care visits on hold. With many primary care practices re-opening, patients should schedule a visit with their primary care provider to ensure that vaccinations and exams are up to date. Those with chronic respiratory illnesses must also keep up with their treatments. This will help maintain optimal health.

“Patients need to understand that their respiratory health is at higher risk this fall, but there are steps they can take to protect themselves,” said Thomas. “NPs can be valuable partners in helping patients take control of their lung health and overall care — but it starts with wearing a mask in public, getting a flu vaccine, eliminating bad habits, reducing needless exposure to poor air quality and consulting with your health care provider if you’re symptomatic. Let’s do everything possible to protect our lungs and our health.”

Share article on social media or email:

Collaboration Perspectives from the Laboratory and Antimicrobial Stewardship, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

This informative webinar will feature two speakers from the University of Pittsburgh Medical Center who will dive into the collaborative efforts between the Clinical Microbiology Laboratory and the Antimicrobial Stewardship Team to adopt and implement the rapid sample-to-answer ePlex® Blood Culture Identification Gram-Positive (BCID-GP) Panel, which detects 20 bacterial targets, 4 antimicrobial resistance genes associated with Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus (VRE) along with two Pan targets that help to identify a wide array of gram-negative bacteria and 4 of the most prevalent Candida species from a positive blood culture.

From the laboratory perspective, the Clinical Microbiologist will focus on laboratory changes needed to adopt a rapid diagnostic panel for the detection of gram-positive bloodstream infections, including the validation, workflow, quality assurance and reporting of this test into the Laboratory Information System and EMR. From the Antimicrobial Stewardship perspective, an Infectious Diseases Pharmacist will define the roadmap for translating the BCID-GP Panel results into optimized patient care algorithms, including real-time stewardship interventions based on organism identification and detection of resistance genes.

Join Stephanie L. Mitchell, Ph.D., D(ABMM), Director of Clinical Microbiology at UPMC Children’s Hospital of Pittsburgh, Assistant Director of Clinical Microbiology at UPMC, Assistant Professor of Pathology, Associate Professor of Infectious Disease and Microbiology, University of Pittsburgh and Ryan K. Shields, PharmD, MS, Associate Director, Antibiotic Management Program, Division of Infectious Diseases, Associate Professor of Medicine, University of Pittsburgh in a live webinar on Monday, October 19, 2020 at 2pm EDT.

For more information or to register for this event, visit Management of Gram-Positive Bloodstream Infections: Collaboration Perspectives from the Laboratory and Antimicrobial Stewardship.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

How Will a Second Wave of COVID-19 Impact the Regulatory Landscape? Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

Plus, we’ll share some tips for staying abreast of the rapid changes so you can quickly adapt and keep trials running because we all know patients can’t afford to wait.

The regulatory landscape has shifted in the wake of COVID-19. Regulatory bodies have made concessions and released guidance in an effort to allow clinical trials to continue and also to get COVID studies up and running in record time. At the same time, the European Union (EU) has issued major judgments on Privacy and HIPAA that will also affect the industry long-term.

In this webinar, we will take a deep dive into how the regulatory changes made as a result of COVID-19 have and will continue to impact data management of clinical trials across the globe. We’ll also discuss what the future holds with regard to the recent EU rulings. Plus, we’ll share some tips for staying abreast of the rapid changes so you can quickly adapt and keep trials running because we all know patients can’t afford to wait.

Join Simone Knab, Clinical Data Architect, SK Data Consulting Pty, Ltd. in a live webinar on Tuesday, October 20, 2020 at 10am EDT (3pm BST/UK).

For more information or to register for this event, visit How Will a Second Wave of COVID-19 Impact the Regulatory Landscape?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Podiatry Growth Partners Announces Partnership with Podiatry Associates


News Image

“I am excited to partner with Podiatry Growth Partners,” said Dr. Oberholtzer-Classen.

Podiatry Growth Partners (the “Company”), a leading management and growth partner to podiatry clinics, today announced a strategic partnership with Podiatry Associates, P.C. (http://www.footdoctorscolorado.com), the largest and most prominent podiatry practice in Colorado.

Led by Dr. Cynthia Oberholtzer-Classen and Mike Classen, Podiatry Associates’ nine podiatrists and two physical therapists have served Douglas County, the Denver metropolitan area, and the surrounding areas for over 20 years. The practice is dedicated to helping the patients in its communities live healthy lives, without foot and ankle pain. “Dr. O.” and her team focus on providing efficient, one-stop patient-friendly services with the highest quality of podiatric care. Podiatry Associates is particularly well-known for sports medicine care, foot and ankle surgery, and quality custom orthotics, which the practice is able to produce quickly and efficiently from its own nearby custom orthotics lab.

“I am excited to partner with Podiatry Growth Partners,” said Dr. Oberholtzer-Classen. “Over the last 20 years, we have built Podiatry Associates into the regional leader in podiatry, with a strong reputation for clinical excellence. Simply put, we love serving our patients and providing them with the best care in the business. It was important to us to pick a partner that shared our commitment to clinical excellence. We have found the perfect partner in Podiatry Growth Partners.”

“With Podiatry Growth Partners, we’ve found a partner that will help us continue to grow while preserving our fundamental practice identity,” said Mr. Classen. “We see an incredible opportunity to expand the Podiatry Associates brand in Denver and throughout the Rocky Mountain region. Podiatry Growth Partners shares this vision with us.”

“We’re thrilled to welcome Podiatry Associates to the Podiatry Growth Partners family,” said David Weiss, Chief Executive Officer of Podiatry Growth Partners. “The practice is a leader at the local, regional, and national levels. Its doctors and staff provide the highest quality of care to current patients, and this investment will allow them to continue their growth trajectory – adding more locations, doctors, and patients.”

Weiss continued, “With Dr. Oberholtzer-Classen now serving as our Chief Medical Officer and Mike Classen as our Chief Operating Officer, we’re building the preeminent national, integrated group of podiatry practices in the country. If you are a growth-oriented podiatrist who is interested in exploring a partnership with Podiatry Growth Partners, please email us at info@podiatry-partner.com.”

About Podiatry Growth Partners

Based in St. Louis, Missouri, and backed by private equity investors Compass Group Equity Partners (http://www.cgep.com), VSS (http://www.vss.com), Siguler Guff (http://www.sigulerguff.com), and SunGate Capital, Podiatry Growth Partners is a leading owner and operator of regionally branded podiatry clinics. The Company is actively seeking to partner with growth-oriented independent podiatrists and podiatry groups. For more information about joining the Podiatry Growth Partners team, please visit http://www.podiatry-partners.com.

Share article on social media or email: